Biologics are more effective at treating adult-onset Still’s disease (AOSD) than are glucocorticoids or conventional disease-modifying antirheumatic drugs (DMARDs), according to a new retrospective ...

The incidence of serious adverse events did not differ significantly between combo therapy and monotherapy in patients with immune-mediated inflammatory diseases. However, specific combinations such ...

Editor's note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Before the JAK inhibitors came out, we had ...

Still's disease is an unusual form of arthritis that, in children, is also called systemic juvenile idiopathic arthritis, but it can also develop in adults. Few rigorous studies have examined biologic ...

The treat-to-target approach represented a stepped-up model for chronic disease management that only became possible when the available therapies showed the potential for disease remission. The ...

In their "Impact of delay of treatment with disease-modifying antirheumatic drugs (DMARDs) in psoriatic arthritis: The CorEvitas psoriatic arthritis/spondyloarthritis registry," published in ACR Open ...

Please provide your email address to receive an email when new articles are posted on . More than 80% of patients with RA successfully discontinued prednisolone at 7 weeks. By 24 months, 95% of ...

Juvenile idiopathic arthritis (JIA) encompasses a group of pediatric inflammatory arthritides that includes oligoarticular JIA, polyarticular JIA, systemic JIA, psoriatic JIA, and enthesitis-related ...

Long-term research indicates that starting rheumatoid arthritis patients on targeted biologic drugs like TNF inhibitors from diagnosis may reduce or delay progression to difficult-to-treat disease, ...